Buffalo General Hospital

Buffalo, New York 55313

1 studies enrolling now · 22 studies all time

What they study most

Acute Coronary Syndrome, Acute Ischemic Stroke, Atherosclerosis, Atrial Fibrillation, Bleeding, Cerebrovascular Accident, Congestive Heart Failure, Coronary Artery Disease, Coronary Restenosis, Coronary Stenosis, End Stage Renal Disease, Epilepsies, Partial

Studies at this site

• Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature — Recruiting now
• Amplatzer Amulet LAAO vs. NOAC — Running, not enrolling
• Surveying Patient's Interest in Robotic Rehabilitation Device — Running, not enrolling
• TRILUMINATE Pivotal Trial — Running, not enrolling
• The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study — Completed
• ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI) — Completed
• Multicenter Selective Lymphadenectomy Trial II (MSLT-II) — Completed
• Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo — Completed
• Effects of Dalfampridine on Cognition in Multiple Sclerosis — Completed
• Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study) — Completed
• Phase III Acute Coronary Syndrome — Stopped early
• A Study to Assess the Safety and Efficacy of Alefacept in Kidney Transplant Recipients — Completed
• Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia — Completed
• Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial — Completed
• Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection — Status unconfirmed
• A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke — Stopped early
• Stage IV Surgery Versus Best Medical Therapy — Stopped early
• Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure. — Completed
• Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis — Completed
• Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stents to Treat De Novo Coronary Lesions — Completed
• A Study to Evaluate the Effects of YM872 on Stroke Lesion Volume in Acute Stroke Patients — Completed
• A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator) — Completed